Inhalable Microparticles Embedding Calcium Phosphate Nanoparticles for Heart Targeting: The Formulation Experimental Design

Inhalation of Calcium Phosphate nanoparticles (CaPs) has recently unmasked the potential of this nanomedicine for a respiratory lung-to-heart drug delivery targeting the myocardial cells. In this work, we investigated the development of a novel highly respirable dry powder embedding crystalline CaPs...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Eride Quarta, Fabio Sonvico, Ruggero Bettini, Claudio De Luca, Alessandro Dotti, Daniele Catalucci, Michele Iafisco, Lorenzo Degli Esposti, Gaia Colombo, Giovanna Trevisi, Dimitrios M. Rekkas, Alessandra Rossi, Tin Wui Wong, Francesca Buttini, Paolo Colombo
Formato: article
Lenguaje:EN
Publicado: MDPI AG 2021
Materias:
Acceso en línea:https://doaj.org/article/96ecb788072c4ea29f9c14e7e96dcf15
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:96ecb788072c4ea29f9c14e7e96dcf15
record_format dspace
spelling oai:doaj.org-article:96ecb788072c4ea29f9c14e7e96dcf152021-11-25T18:40:57ZInhalable Microparticles Embedding Calcium Phosphate Nanoparticles for Heart Targeting: The Formulation Experimental Design10.3390/pharmaceutics131118251999-4923https://doaj.org/article/96ecb788072c4ea29f9c14e7e96dcf152021-11-01T00:00:00Zhttps://www.mdpi.com/1999-4923/13/11/1825https://doaj.org/toc/1999-4923Inhalation of Calcium Phosphate nanoparticles (CaPs) has recently unmasked the potential of this nanomedicine for a respiratory lung-to-heart drug delivery targeting the myocardial cells. In this work, we investigated the development of a novel highly respirable dry powder embedding crystalline CaPs. Mannitol was selected as water soluble matrix excipient for constructing respirable dry microparticles by spray drying technique. A Quality by Design approach was applied for understanding the effect of the feed composition and spraying feed rate on typical quality attributes of inhalation powders. The in vitro aerodynamic behaviour of powders was evaluated using a medium resistance device. The inner structure and morphology of generated microparticles were also studied. The 1:4 ratio of CaPs/mannitol led to the generation of hollow microparticles, with the best aerodynamic performance. After microparticle dissolution, the released nanoparticles kept their original size.Eride QuartaFabio SonvicoRuggero BettiniClaudio De LucaAlessandro DottiDaniele CatalucciMichele IafiscoLorenzo Degli EspostiGaia ColomboGiovanna TrevisiDimitrios M. RekkasAlessandra RossiTin Wui WongFrancesca ButtiniPaolo ColomboMDPI AGarticlecalcium phosphate nanoparticlesmicroparticles embedding nanoparticlesdesign of experimentpulmonary deliveryPharmacy and materia medicaRS1-441ENPharmaceutics, Vol 13, Iss 1825, p 1825 (2021)
institution DOAJ
collection DOAJ
language EN
topic calcium phosphate nanoparticles
microparticles embedding nanoparticles
design of experiment
pulmonary delivery
Pharmacy and materia medica
RS1-441
spellingShingle calcium phosphate nanoparticles
microparticles embedding nanoparticles
design of experiment
pulmonary delivery
Pharmacy and materia medica
RS1-441
Eride Quarta
Fabio Sonvico
Ruggero Bettini
Claudio De Luca
Alessandro Dotti
Daniele Catalucci
Michele Iafisco
Lorenzo Degli Esposti
Gaia Colombo
Giovanna Trevisi
Dimitrios M. Rekkas
Alessandra Rossi
Tin Wui Wong
Francesca Buttini
Paolo Colombo
Inhalable Microparticles Embedding Calcium Phosphate Nanoparticles for Heart Targeting: The Formulation Experimental Design
description Inhalation of Calcium Phosphate nanoparticles (CaPs) has recently unmasked the potential of this nanomedicine for a respiratory lung-to-heart drug delivery targeting the myocardial cells. In this work, we investigated the development of a novel highly respirable dry powder embedding crystalline CaPs. Mannitol was selected as water soluble matrix excipient for constructing respirable dry microparticles by spray drying technique. A Quality by Design approach was applied for understanding the effect of the feed composition and spraying feed rate on typical quality attributes of inhalation powders. The in vitro aerodynamic behaviour of powders was evaluated using a medium resistance device. The inner structure and morphology of generated microparticles were also studied. The 1:4 ratio of CaPs/mannitol led to the generation of hollow microparticles, with the best aerodynamic performance. After microparticle dissolution, the released nanoparticles kept their original size.
format article
author Eride Quarta
Fabio Sonvico
Ruggero Bettini
Claudio De Luca
Alessandro Dotti
Daniele Catalucci
Michele Iafisco
Lorenzo Degli Esposti
Gaia Colombo
Giovanna Trevisi
Dimitrios M. Rekkas
Alessandra Rossi
Tin Wui Wong
Francesca Buttini
Paolo Colombo
author_facet Eride Quarta
Fabio Sonvico
Ruggero Bettini
Claudio De Luca
Alessandro Dotti
Daniele Catalucci
Michele Iafisco
Lorenzo Degli Esposti
Gaia Colombo
Giovanna Trevisi
Dimitrios M. Rekkas
Alessandra Rossi
Tin Wui Wong
Francesca Buttini
Paolo Colombo
author_sort Eride Quarta
title Inhalable Microparticles Embedding Calcium Phosphate Nanoparticles for Heart Targeting: The Formulation Experimental Design
title_short Inhalable Microparticles Embedding Calcium Phosphate Nanoparticles for Heart Targeting: The Formulation Experimental Design
title_full Inhalable Microparticles Embedding Calcium Phosphate Nanoparticles for Heart Targeting: The Formulation Experimental Design
title_fullStr Inhalable Microparticles Embedding Calcium Phosphate Nanoparticles for Heart Targeting: The Formulation Experimental Design
title_full_unstemmed Inhalable Microparticles Embedding Calcium Phosphate Nanoparticles for Heart Targeting: The Formulation Experimental Design
title_sort inhalable microparticles embedding calcium phosphate nanoparticles for heart targeting: the formulation experimental design
publisher MDPI AG
publishDate 2021
url https://doaj.org/article/96ecb788072c4ea29f9c14e7e96dcf15
work_keys_str_mv AT eridequarta inhalablemicroparticlesembeddingcalciumphosphatenanoparticlesforhearttargetingtheformulationexperimentaldesign
AT fabiosonvico inhalablemicroparticlesembeddingcalciumphosphatenanoparticlesforhearttargetingtheformulationexperimentaldesign
AT ruggerobettini inhalablemicroparticlesembeddingcalciumphosphatenanoparticlesforhearttargetingtheformulationexperimentaldesign
AT claudiodeluca inhalablemicroparticlesembeddingcalciumphosphatenanoparticlesforhearttargetingtheformulationexperimentaldesign
AT alessandrodotti inhalablemicroparticlesembeddingcalciumphosphatenanoparticlesforhearttargetingtheformulationexperimentaldesign
AT danielecatalucci inhalablemicroparticlesembeddingcalciumphosphatenanoparticlesforhearttargetingtheformulationexperimentaldesign
AT micheleiafisco inhalablemicroparticlesembeddingcalciumphosphatenanoparticlesforhearttargetingtheformulationexperimentaldesign
AT lorenzodegliesposti inhalablemicroparticlesembeddingcalciumphosphatenanoparticlesforhearttargetingtheformulationexperimentaldesign
AT gaiacolombo inhalablemicroparticlesembeddingcalciumphosphatenanoparticlesforhearttargetingtheformulationexperimentaldesign
AT giovannatrevisi inhalablemicroparticlesembeddingcalciumphosphatenanoparticlesforhearttargetingtheformulationexperimentaldesign
AT dimitriosmrekkas inhalablemicroparticlesembeddingcalciumphosphatenanoparticlesforhearttargetingtheformulationexperimentaldesign
AT alessandrarossi inhalablemicroparticlesembeddingcalciumphosphatenanoparticlesforhearttargetingtheformulationexperimentaldesign
AT tinwuiwong inhalablemicroparticlesembeddingcalciumphosphatenanoparticlesforhearttargetingtheformulationexperimentaldesign
AT francescabuttini inhalablemicroparticlesembeddingcalciumphosphatenanoparticlesforhearttargetingtheformulationexperimentaldesign
AT paolocolombo inhalablemicroparticlesembeddingcalciumphosphatenanoparticlesforhearttargetingtheformulationexperimentaldesign
_version_ 1718410850173190144